• LNP Bleb Structures Improve mRNA Transfection

  2026-10-01

  The reference study shows that high-concentration acidic citrate formulation can induce mRNA-rich bleb structures in lipid nanoparticles containing less active ionizable lipids. These structures were associated with stronger in vitro and in vivo transfection, apparently in part because they improved encapsulated mRNA integrity rather than simply enhancing intracellular delivery.

• Firefly Luciferase mRNA: Practical Assay Guide

  2026-10-01

  Learn how Firefly Luciferase mRNA (ARCA, 5mCTP, ΨUTP), SKU R1005, can improve transfection controls, reporter interpretation, and handling consistency in gene expression and cell viability workflows. This scenario-based guide connects product specifications with practical mRNA formulation and assay-design considerations.

• Epoxomicin in ER Stress Protein Quality Control

  2026-09-30

  Discover how Epoxomicin, a selective proteasome inhibitor, can clarify ER stress, N-degron signaling, and protein quality-control assays. This article translates UBR1/UBR2 findings into experimental design principles beyond conventional degradation workflows.

• CTOP for μ-Opioid Receptor Pain Research

  2026-09-30

  CTOP provides a selective pharmacological way to test whether μ-opioid receptor activity drives receptor signaling, mechanical hypersensitivity, or analgesic tolerance. This workflow connects receptor-level assays with circuit-focused pain research while emphasizing controls, storage, and troubleshooting for reproducible results.

• Tetrandrine: Mechanism-to-Assay Evidence Guide

  2026-09-29

  Tetrandrine is a multifunctional Tetrandrine alkaloid for calcium signaling and translational assay research. This guide connects compound identity, ion-channel pharmacology, and structure-based screening evidence while defining practical limits for antiviral, inflammation, neuroscience, and cancer studies.

• Bacteria-Derived OMVs for mRNA Tumor Vaccines

  2026-09-29

  Li et al. developed engineered outer membrane vesicles that rapidly bind sequence-tagged mRNA antigens and promote dendritic-cell delivery and cross-presentation. The platform inhibited tumor growth, produced complete regression in a subset of mice, and generated durable antitumor immune memory, while offering a delivery concept distinct from lipid nanoparticles.

• Meropenem trihydrate in Resistance Research

  2026-09-28

  Meropenem trihydrate supports more than antibacterial susceptibility testing: it can serve as a controlled perturbation for resistance phenotyping, LC-MS/MS metabolomics, and mechanistic bacterial infection treatment research. This workflow-oriented guide shows how to improve assay comparability, connect metabolic signatures with carbapenem response, and troubleshoot common reagent and data-quality problems.

• Gamithromycin PK/PD in Cattle: Tissue-Cage Evidence

  2026-09-28

  A 2025 cattle tissue-cage study linked gamithromycin exposure to antibacterial effects against Pasteurella multocida and identified AUC0–24h/MIC as the most informative PK/PD index among those assessed. Its compartment-specific target estimates offer a framework for interpreting exposure in serum and inflammatory fluids, while the model’s limits caution against treating them as direct lung or clinical dosing targets.

• O6-Benzylguanine: MGMT Inhibition Workflows

  2026-09-27

  Use O6-Benzylguanine to distinguish direct MGMT enzyme inhibition from gene-expression changes when testing alkylator response. This practical workflow pairs activity measurements with DNA-damage and viability readouts, with controls to help separate sensitization from compound or vehicle effects.

• Tin Mesoporphyrin IX: HO Inhibition Research Guide

  2026-09-26

  Tin Mesoporphyrin IX (chloride) is a competitive inhibitor of heme oxygenase activity with a reported in vitro Ki of 14 nM against rat splenic microsomal heme oxygenase. It is a tool for studying heme catabolism, but the cited hepatitis B study examined HO-1 induction by isochlorogenic acid A and did not test Tin Mesoporphyrin IX.

• AP-2α Suppresses MGMT in Recurrent GBM

  2026-09-25

  The study links AP-2α directly to repression of MGMT, a DNA-repair enzyme associated with temozolomide resistance in recurrent glioblastoma. Cell and mouse experiments suggest that restoring AP-2α, including through retinoic acid signaling, can increase DNA-damage readouts and improve responses to temozolomide, although further work is needed to establish clinical relevance.

• CD40–STING–TRAF2 Signaling in ESCC TLS

  2026-09-25

  A study of treatment-naïve esophageal squamous cell carcinoma links tertiary lymphoid structures with favorable survival and identifies IRF4-high B cells as a prominent immune feature. Its mechanistic experiments suggest that CD40 and STING compete for TRAF2, influencing STING modification and non-canonical NF-κB signaling during B-cell activation.

• From Cilia Biology to Selective HDAC6 Research

  2026-09-24

  SMPD4 research reveals how lipid metabolism supports neural progenitor survival and primary cilia development. Here, we connect that insight cautiously to Rocilinostat (ACY-1215), outlining how translational researchers can use selective HDAC6 inhibition to test cancer-relevant mechanisms without conflating distinct pathways or overextending preclinical findings.

• IBDV VP3 Disrupts IRF7 to Promote Viral Replication

  2026-09-24

  A 2025 study identifies IBDV VP3 as a viral factor that interferes with IRF7 abundance and type I interferon signaling, helping very virulent IBDV replicate in chicken cells. The findings connect viral protein interactions with proteasome-associated IRF7 loss and suggest experiments to distinguish transcriptional suppression from protein turnover.

• Firefly Luciferase mRNA: Practical Assay Workflows

  2026-09-23

  Build a reproducible bioluminescent readout for transfection optimization, gene expression, and delivery studies with a modified firefly reporter. This guide pairs practical assay steps with clear limits on what luminescence can—and cannot—tell you about cell viability, nanoparticle delivery, and immune memory.

8471 records 1/565 page Next 12345 下5页 Last page